The effects of abundant plasma protein depletion on global glycan profiling using NanoLC FT-ICR mass spectrometry

Bereman, Michael S.; Muddiman, David C.
February 2010
Analytical & Bioanalytical Chemistry;Feb2010, Vol. 396 Issue 4, p1473
Academic Journal
We report the results of abundant plasma protein depletion on the analysis of underivatized N-linked glycans derived from plasma proteins by nanoLC Fourier-transform ion cyclotron resonance mass spectrometry. N-linked glycan profiles were compared between plasma samples where the six most abundant plasma proteins were depleted ( n = 3) through a solid-phase immunoaffinity column and undepleted plasma samples ( n = 3). Three exogenous glycan standards were spiked into all samples which allowed for normalization of the N-glycan abundances. The abundances of 20 glycans varying in type, structure, composition, and molecular weight (1,200–3,700 Da) were compared between the two sets of samples. Small fucosylated non-sialylated complex glycans were found to decrease in abundance in the depleted samples (greater than or equal to tenfold) relative to the undepleted samples. Protein depletion was found to marginally effect (less than threefold) the abundance of high mannose, hybrid, and large highly sialylated complex species. The significance of these findings in terms of future biomarker discovery experiments via global glycan profiling is discussed.


Related Articles

  • Serum protein biomarkers screening in HCC patients with liver cirrhosis by ICAT-LC-MS/MS. Xiaonan Kang; Lu Sun; Kun Guo; Hong Shu; Jun Yao; Xue Qin; Yinkun Liu // Journal of Cancer Research & Clinical Oncology;Aug2010, Vol. 136 Issue 8, p1151 

    The prognosis of HCC remains poor mainly because of the lack of diagnosis biomarkers especially in patients with cirrhosis background. To identify serum biomarkers for HCC, we use cleavable stable isotope labeling (cICAT) combined with LC–electrospray ionization tandem mass spectrometry...

  • The Effect of Pre-Analytical Variability on the Measurement of MRM-MS-Based Mid- to High- Abundance Plasma Protein Biomarkers and a Panel of Cytokines. Aguilar-Mahecha, Adriana; Kuzyk, Michael A.; Domanski, Dominik; Borchers, Christoph H.; Basik, Mark // PLoS ONE;Jun2012, Vol. 7 Issue 6, p1 

    Blood sample processing and handling can have a significant impact on the stability and levels of proteins measured in biomarker studies. Such pre-analytical variability needs to be well understood in the context of the different proteomics platforms available for biomarker discovery and...

  • Searching for early breast cancer biomarkers by serum protein profiling of pre-diagnostic serum; a nested case-control study.  // BMC Cancer;2011, Vol. 11 Issue 1, p381 

    The article presents a cohort analysis that presents the use of pre-diagnostic serum protein profiles for breast cancer by using Prospect-EPIC (European Prospective Investigation into Cancer and nutrition). The study was conducted on 68 women having breast cancer and the surface enhanced laser...

  • Approaches to dimensionality reduction in proteomic biomarker studies. Hilario, Melanie; Kalousis, Alexandros // Briefings in Bioinformatics;Mar2008, Vol. 9 Issue 2, p102 

    Mass-spectra based proteomic profiles have received widespread attention as potential tools for biomarker discovery and early disease diagnosis. A major data-analytical problem involved is the extremely high dimensionality (i.e. number of features or variables) of proteomic data, in particular...

  • Identification of differential signs of squamous cell lung carcinoma by means of the mass spectrometry profiling of blood plasma. Pyatnitskiy, M.; Lisitsa, A.; Moshkovskii, S.; Arnotskaya, N.; Akhmedov, B.; Zaridze, D.; Polotskii, B.; Shevchenko, V. // Journal of Analytical Chemistry;Dec2011, Vol. 66 Issue 14, p1369 

    The study deals with the search for potential biomarkers of squamous cell lung cancer by virtue of low-molecular weight proteome profiling (1-20 kDa) of blood plasma. The profiling was performed by automated sample preparation followed by matrix-assisted laser desorption/ionization...

  • Quality control and quality assessment of data from surface-enhanced laser desorption/ionization (SELDI) time-of flight (TOF) mass spectrometry (MS). Huixiao Hong; Dragan, Yvonne; Epstein, Joshua; Teitel, Candee; Bangzheng Chen; Qian Xie; Hong Fang; Leming Shi; Perkins, Roger; Weida Tong // BMC Bioinformatics;2005 Supplement 2, Vol. 6, pS5 

    Background: Proteomic profiling of complex biological mixtures by the ProteinChip technology of surface-enhanced laser desorption/ionization time-of-flight (SELDI-TOF) mass spectrometry (MS) is one of the most promising approaches in toxicological, biological, and clinic research. The reliable...

  • Protein mass spectra data analysis for clinical biomarker discovery: a global review. Roy, Pascal; Truntzer, Caroline; Maucort-Boulch, Delphine; Jouve, Thomas; Molinari, Nicolas // Briefings in Bioinformatics;Mar2011, Vol. 12 Issue 2, p176 

    The identification of new diagnostic or prognostic biomarkers is one of the main aims of clinical cancer research. In recent years there has been a growing interest in using high throughput technologies for the detection of such biomarkers. In particular, mass spectrometry appears as an exciting...

  • Proteomics approaches to biomarker detection. Ming Zhou; Conrads, Thomas P.; Veenstra, Timothy D. // Briefings in Functional Genomics & Proteomics;May2005, Vol. 4 Issue 1, p69 

    The development of mass spectrometry (MS) technologies has brought the ability to gather massive amounts of data characterising the proteomes of complex mixtures. A major focus in proteomics is to leverage this data-gathering capability to conduct comparative analyses of biofluids from healthy...

  • Characterising and correcting batch variation in an automated direct infusion mass spectrometry (DIMS) metabolomics workflow. Kirwan, J.; Broadhurst, D.; Davidson, R.; Viant, M. // Analytical & Bioanalytical Chemistry;Jun2013, Vol. 405 Issue 15, p5147 

    Direct infusion mass spectrometry (DIMS)-based untargeted metabolomics measures many hundreds of metabolites in a single experiment. While every effort is made to reduce within-experiment analytical variation in untargeted metabolomics, unavoidable sources of measurement error are introduced....


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics